Advancements in cell and gene therapies (CGTs) have revolutionized treatment for complex diseases, exemplified by Emily Whitehead’s remarkable journey as the first pediatric CAR-T therapy patient, now cancer-free after 13 years.

Yet, as therapies become more sophisticated, logistics become increasingly critical. Ensuring precise, timely delivery within stringent temperature and environmental controls is more vital than ever. Cutting-edge innovations, from real-time monitoring and AI-powered predictive technologies to proactive intervention strategies, are reshaping the supply chain.

In this compelling feature, Rohin Iyer, Ph.D., Marken’s Senior Director of Global Cell and Gene Operations, shares insights into this rapidly evolving landscape. Discover how precision logistics is enhancing patient access to groundbreaking therapies.